Day: October 20, 2025

LEIDEN, Netherlands & CAMBRIDGE, Mass., Oct. 20, 2025 (GLOBE NEWSWIRE) — ProQR Therapeutics N.V. (Nasdaq: PRQR) (ProQR), a company dedicated to changing lives through transformative RNA therapies based on its proprietary Axiomer™ RNA editing technology platform, today announced that following review under the new European Medicines Agency (EMA) centralized review process, the Central Committee on Research Involving Human Subjects (CCMO) has authorized ProQR’s Clinical Trial Application (CTA) for a Phase 1 study of AX-0810 in healthy volunteers. AX-0810 is the Company’s lead investigational editing oligonucleotide (EON) targeting NTCP, which is being developed for the treatment of cholestatic diseases like primary sclerosing cholangitis and biliary atresia. With this CTA approval, ProQR is authorized to begin dosing...

Collaboration Expected to Advance FS2 Topical Platform and Strengthen BGLC’s Biotech Footprint in Asia KUALA LUMPUR, Malaysia, Oct. 20, 2025 (GLOBE NEWSWIRE) — BioNexus Gene Lab Corp (Nasdaq: BGLC, “BGLC”, or the “Company”), today announced that it has entered into a non-binding Strategic Partnership Term Sheet with BirchBioMed Inc. (“Birch”), a Canadian biopharmaceutical company developing regenerative treatments for organ fibrosis, topical scarring and autoimmune diseases. Under the non-binding term sheet, BGLC would lead Birch’s USD $10 million upcoming financing round through a strategic equity investment and collaboration to accelerate commercialization of Birch’s FS2 (kynurenic acid) topical platform in Southeast Asia. The partnership is designed to combine BGLC’s regional market access and infrastructure with Birch’s novel...

Management to host conference call on Thursday, October 30, 2025, at 8:00 am EDTFLORHAM PARK, N.J., Oct. 20, 2025 (GLOBE NEWSWIRE) — Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a biopharmaceutical company focused on developing and commercializing novel treatments for gastrointestinal diseases, today announced that it will host a live webcast at 8:00 am EDT on Thursday, October 30, 2025, to report its third quarter 2025 financial results and provide a business update. A live webcast and additional information about the presentation can be accessed on the Events & Presentations section of the Phathom website at https://investors.phathompharma.com/news-events/events-and-presentations. A recording will be available for 90 days following the conclusion of the call. About Phathom Pharmaceuticals, Inc. Phathom Pharmaceuticals...

BOSTON, Oct. 20, 2025 (GLOBE NEWSWIRE) — CervoMed Inc. (NASDAQ: CRVO), a clinical stage company focused on developing treatments for age-related neurologic disorders (CervoMed or the Company), today announced that Matthew Winton, Ph.D., Chief Commercial and Business Officer, will present at the Emerging Growth Conference, being held virtually on Wednesday, October 22, 2025. Presentation DetailsFormat: Corporate PresentationDate: Wednesday, October 22, 2025Time: 11:25 – 11:55 AM ETWebcast Link: https://goto.webcasts.com/starthere.jsp?ei=1717092&tp_key=1ddfafa563&sti=crvo The webcast and replay of the presentation will be accessible in the Investor section of the CervoMed website https://www.cervomed.com/. About CervoMedCervoMed is a clinical-stage company focused on developing treatments for age-related neurologic disorders....

WEST PALM BEACH, Fla., Oct. 20, 2025 (GLOBE NEWSWIRE) — Sunrise Realty Trust, Inc. (“SUNS” or the “Company”) (Nasdaq: SUNS), a lender on the Tannenbaum Capital Group (“TCG”) Real Estate platform, today announced that it has committed $25.6 million to a $36.6 million senior loan commitment originated by TCG Real Estate for the financing of the CollectionSuites, an industrial-for-sale development including two projects located in Doral and Palm Springs, Florida (together, “CollectionSuites” or the “Project”). Affiliated lenders on the TCG Real Estate platform committed the remaining $11.0 million to the senior loan financing. The Sponsor of the Project, JMF Consulting (“JMF” or the “Sponsor”), is headquartered in Doral and has expertise in the design and development of premium and highly secure real estate projects. The Project introduces...

EL SEGUNDO, Calif., Oct. 20, 2025 (GLOBE NEWSWIRE) — A-Mark Precious Metals, Inc. (NASDAQ: AMRK) (A-Mark), a leading fully integrated precious metals platform, will hold a conference call on Thursday, November 6, 2025, at 4:30 p.m. Eastern time to discuss results for the fiscal first quarter ended September 30, 2025. Financial results will be issued in a press release prior to the call. A-Mark management will host the presentation, followed by a question-and-answer period. A-Mark’s conference call can be accessed as follows: Date: Thursday, November 6, 2025Time: 4:30 p.m. Eastern time (1:30 p.m. Pacific time)Webcast: https://www.webcaster5.com/Webcast/Page/2867/53131 U.S. dial-in number: 1-888-506-0062International number: 1-973-528-0011Participant Access Code: 974548 Please call the conference telephone number 10 minutes before...

 FalconX and Bridgewater Alum Matthew Sheffield Named Chief Investment Officer Former Bain Capital Crypto Head of Marketing Mandy Campbell Named Chief Marketing Officer Consensys and J.P. Morgan Veteran Michael Camarda Named Chief Development Officer Minneapolis, MN, Oct. 20, 2025 (GLOBE NEWSWIRE) — SharpLink Gaming, Inc. (Nasdaq: SBET) (“SharpLink” or the “Company”), one of the world’s largest corporate holders of Ether (“ETH”) and prominent industry advocate of Ethereum adoption, today announced the expansion of its senior leadership team with three key appointments that further strengthen and enhance SharpLink’s executive bench of world class institutional and digital asset experts. Specifically, SharpLink has named industry veterans Matthew Sheffield as Chief Investment Officer, Mandy Campbell as Chief Marketing Officer and...

WALTHAM, Mass., Oct. 20, 2025 (GLOBE NEWSWIRE) — OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of healthcare technology solutions helping life sciences companies reach and engage healthcare professionals (HCPs) and patients, will hold a conference call on Thursday, November 6, 2025, at 4:30 p.m. Eastern Time to discuss its results for the third quarter period ended September 30, 2025. The financial results will be issued in a press release prior to the call. OptimizeRx management will host the call, followed by a question-and-answer period. Details for the conference call can be found below:Date: Thursday, November 6, 2025Time: 4:30 p.m. Eastern Time (1:30 p.m. Pacific Time)Toll Free: 1-844-825-9789International: 1-412-317-5180Conference ID: 10203796Call me™ Link: https://callme.viavid.com/?$Y2FsbG1lPXRydWUmcGFzc2NvZGU9JmluZm89Y29tcGFueSZyPXRydWUmYj0xNg==Call...

5.77% average yield, demonstrates Oportun’s continued access to low-cost funding  Third consecutive transaction with AAA rating on most senior bonds SAN CARLOS, Calif., Oct. 20, 2025 (GLOBE NEWSWIRE) — Oportun (Nasdaq: OPRT), a mission-driven financial services company, today announced the issuance of $441 million of two-year revolving fixed rate asset-backed notes secured by a pool of unsecured and secured installment loans. The offering included five classes of fixed rate notes: Class A, Class B, Class C, Class D, and Class E. Fitch rated all classes of notes, assigning ratings of AAA, AA-, A-, BBB-, and BB-, respectively. Deutsche Bank Securities Inc served as the sole structuring agent and co-lead, and Goldman Sachs & Co. LLC, Jefferies LLC and Natixis Corporate & Investment Banking also served as co-leads. The weighted...

Tokyo, Japan, Oct. 20, 2025 (GLOBE NEWSWIRE) — Tokyo Lifestyle Co., Ltd. (“Tokyo Lifestyle” or the “Company”) (Nasdaq: TKLF), a retailer and wholesaler of Japanese beauty and health products, sundry products, luxury products, electronic products, collectible cards, trendy toys as well as other products in Hong Kong, Japan, North America, Thailand and the United Kingdom, today announced that its Hong Kong subsidiary, Tokyo Lifestyle Limited, had entered a cooperation agreement along with a supplementary agreement (collectively, the “Agreements”) with HK Artemis Limited (“HK Artemis”), a Hong Kong-based private company, to jointly drive the online sales through the Company’s shopping mall app (the “App”) in Hong Kong. Pursuant to the Agreements, Tokyo Lifestyle agrees to transfer ownership of the App to HK Artemis by January 1, 2026,...